MedTrace Logo

Remote Digital Care Effects in Adolescents With Type 1 Diabetes

NCT05421715 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-05-08

No results posted yet for this study

Summary

Pilot study to evaluate effects of an experimental additional remote digital care (TELEDUC-DIAB) to adolescents with poorly controlled type 1 diabetes using digital monitoring platform and educative app

Conditions

  • type1diabetes

Interventions

OTHER

TELEDUC-DIAB

* Systematic monthly remote monitoring between traditional face-to-face consultations by a medical researcher using Kidia and My Diabby digital devices: * With downloading by the adolescent of all data on My Diabby platform (clinical data from diabetes monitoring) * Evaluation of adverse events related to the treatment of diabetes (hospitalizations and concomitant treatment) * Analysis of data collected via My Diabby and Kidia: glycemic balance, captured data, connection frequency, alerts and alarms, diabetes knowledge) * The proposal of a therapeutic education session according to the needs of the adolescent via the Kidia application * Treatment adaptation * A follow-up in case there is an alert identified by the teenager, the relative or My Diabby/caregiver * The medical orientation of the patient according to the needs identified * A proposal for a therapeutic education session according to the needs of the adolescent via the Kidia application

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Maeva TALVARD, MD · University Hospital, Toulouse

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-11
Primary Completion
2024-10-11
Completion
2024-10-11

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05421715 on ClinicalTrials.gov